The content on this site is intended for healthcare professionals only
Melanoma incidence: signs for a decline?
Prof David Whiteman - QIMR Berghofer Medical Research Institute, Brisbane, Austr...
22 Nov 2018
Can we cure advanced metastatic melanoma patients?
Prof Axel Hauschild - University Hospital, Schleswig-Holstein. Germany
22 Nov 2018
Melanoma Patient Network Europe: Patient advocacy and communication
Dr Bettina Ryll - Founder, Melanoma Patient Network Europe
22 Nov 2018
NRAS mutant melanoma: Targeted therapy, are we there yet?
Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany
22 Nov 2018
Brain metastases: therapeutic options
Prof Brigette Dréno - University Hospital Nantes, Nantes, France
22 Nov 2018
Key topics in melanoma presented at EADO 2018
Dr Josep Malvehy - Hospital Clínic de Barcelona, Barcelona, Spain
22 Nov 2018
EADO 2018: Melanoma roundup with a view to patients
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
22 Nov 2018
Will computers replace the dermatologist?
Dr Susanna Puig - Hospital Clínic de Barcelona, Barcelona, Spain
22 Nov 2018
BRAF/MEK inhibition as adjuvant treatment in melanoma
Dr Jessica Hassel - Heidelberg University Hospital, Heidelberg, Germany
22 Nov 2018
Molecular stratification of melanoma and the high burden of mutations
Dr Joan Anton Puig Butille - Hospital Clínic de Barcelona, Barcelona, Spain
22 Nov 2018
The changing landscape of melanoma treatment
Dr Eva Muñoz-Couselo - University Hospital Vall d'Hebron
22 Nov 2018
Patient advocacy and nursing in melanoma
Virginia Aznar De Carrillo - Melanoma España, Barcelona, Spain
22 Nov 2018
